The cyst-forming apicomplexan parasite Toxoplasma gondii infects a broad spectrum of vertebrates. Domestic and feral cats are the definitive hosts but other animals including humans can be infected by ingestion of oocysts or tissue cysts. Overwhelming infections, especially in an immunosuppressed or immunologically naive animal, may be fatal. Diagnosis can be difficult, especially because infection by other cyst-forming protozoa may have similar clinical and diagnostic features.
Techniques employed for the diagnosis of toxoplasmosis include serology, parasite incubation, immunohistochemistry, and light and electron microscopy. Serology may be inadequate if the host is immunosuppressed, and maternal antibodies may interfere in testing neonates. Commercially available agglutination tests vary in their sensitivity and ability to detect chronic infections. 5 Antigen detection is not 100% accurate because interspecies antigen cross-reactivity has been observed, and tissue culture and mouse inoculation, although specific, are time consuming and potentially expose researchers to a Zoonotic. 4, 11, 13 Histologic diagnosis is most reliable when the organisms are present in encysted form, and even then discrimination from related protozoa such as Neospora caninum may be difficult. The T. gondii tachyzoite is morphologically identical to that of other apicomplexan parasites, including many Zoonotic species. In humans, presumptive diagnosis of T. gondii infection is made from typical alterations in lymph node architecture. 6 No pathognomonic histologic pattern occurs in animal tissues making differentiation by light microscopy between T. gondii and other cyst-forming protozoan parasites, such as Sarcocystis, Besnoitia, Frenkelia, Balantidia, and Neospora, difficult. Application of the polymerase chain reaction (PCR) technique has accurately and quickly detected T. gondii in a variety of different clinical specimens, including formalinfixed, paraffin-embedded tissue. 8, [11] [12] [13] [14] [15] [16] [17] [18] Although PCR techniques have much greater sensitivity when assaying fresh rather than preserved tissue, serial dilution studies demonstrated a high degree of sensitivity for T. gondii in paraffinembedded tissues. 1 PCR-based Toxoplasma assays utilize either the gene encoding the major surface antigen P30, present in 1 copy/organism, or the highly conserved repetitive B1 gene (a gene specific to T. gondii that encodes an unknown serum reactive protein). Approximately 35 copies of the B1 gene are present in the T. gondii genome, but this gene is absent in mammalian cells. 1, 2 Previous studies have shown greater success with amplification of the B1 gene for PCR diagnosis of human toxoplasmosis than occurred when utilizing P30. 1, 13, 15 The repeated short DNA fragments of the B1 gene provide a better amplification target then the longer single copy P30 gene. 15 To evaluate the role of PCR in diagnosis of toxoplasmosis in animals, primers were made for the B1 2 and P30 3 genes, utilizing sequences published from human toxoplasmosis cases, and used for PCR amplification in known Toxoplasma cases in a variety of animals, including marsupials, rodents, birds, ruminants, cats, and dogs. Known cases of other cystforming protozoan parasites also were analyzed in an effort to determine the specificity of the PCR assay. Formalin-fixed, paraffin-embedded tissues from previously identified cerebral and disseminated infections (19 cases) of toxoplasmosis or other cyst-forming protozoa (15 cases) were obtained from the Armed Forces Institute of Pathology archives.
Following histologic reexamination, tissue samples containing cysts or samples containing tachyzoites were sectioned and prepared as previously described. 18 Specimens were sectioned at approximately 5-10 µm thickness by a microtome or by hand if the paraffin block did not fit the microtome. Blades were changed after every sample to avoid cross-contamination. Each tissue section was then placed in a microfuge tube for deparaffinization and was rehydrated as previously reported. 13, 18 PCR buffer (100 µ1) with nonionic detergent containing 10 µg proteinase K was added to each tube for digestion at 52 C. The lysate was ready for PCR once it became clear. Vigorous vortexing and extended digestion were necessary for thicker tissue sections.
Several samples did not show satisfactory PCR results possibly because the lysate did not contain enough Toxoplasma DNA. These specimens were further processed by conventional purification of DNA by phenol/chloroform extraction and ethanol precipitation. The purified sample was then redissolved in a minimal volume of buffer for PCR analysis.
The PCR was performed as previously described. 13 Published sequences furnished information for the oligonucleotide primers of the B1 gene, 2 the gene encoding P30, 3 and the 16s RNA gene, 10 which was used as a control ( Table 1) . The highly conserved 16s RNA gene, whose sequence is similar among such diverse groups as insects and mammals, was used to confirm the presence of amplifiable DNA. Amplification of the B1, P30, and 16s RNA genes produce 194-, 372-, and 652-base-pair (bp) products, respectively. Each PCR (final volume of 50 µ1) contained 10 mM Tris-HC1 (pH 8.0), 50 mM KCl, 1.5 or 2.5 mM MgC1 2 , 0.25 mM deoxynucleoside triphosphates, 0.5 µM primers, 1 unit Taq polymerase, a and 1-1.5 µ1 of sample lysate. After a S-minute initial incubation at 94 C, the sample was subjected to 40 cycles of PCR consisting of 1 minute at 94 C for denaturation, 1 minute at 60 C for annealing, and 1 minute of extension at 72 C followed by 5 minutes of incubation at 72 C before storage at 4 C.
An 18-µ1 aliquot of each PCR product was electrophoresed on a 2.5% agarose gel as previously described. 13 Ethidium bromide staining allowed visualization of DNA bands. Because the 16s RNA gene is a multiple copy gene and highly conserved, ethidium bromide staining of the 652-bp band was adequate to determine its presence. DNA samples amplified with primers for the B1 and P30 genes of T. gondii were analyzed as above, followed by transfer to nylon membranes and hybridization with a 32 P-labeled probe internal to the amplified region ( Table 2) .
Membranes were washed with 0.2x standard saline citrate/0.1% sodium dodecyl sulfate, and autoradiographs were made. Control samples were processed in parallel and consisted of purified DNA from a human infected with Toxoplasma as a positive control and a negative control sample containing only PCR mix lacking template DNA.
B1 gene amplification identified 93.3% of previously histologically diagnosed cases, including 1 case in which no cysts were seen in the tissue sample ( Table 3 , Fig. 1 ). Some cases required further purification or repeated sectioning to obtain a positive diagnosis. When cases were resectioned, tissue was cut from a different area of the block and then processed as before.
Any negative cases were analyzed in a PCR assay using the 16s RNA primers to determine if intact DNA was present after fixation, embedment, and subsequent extraction. The only cases that remained negative for B1 primer amplification also were negative for any product after 16s RNA gene amplification.
Most cases infected by protozoan parasites other than T. gondii were negative for amplification with the B1 primers. Exceptions occurred when co-infection was visible or in some of the Sarcocystis-infected cases ( Table 4 ). Tissues in which infection with a closely related coccidian produced a positive signal for B1 amplification were resectioned, purified, amplified with P30 primers, and probed with the P30 internal sequence. All cases then tested negative. Tissue lysates used in this part of the study were checked for intact DNA by amplification of the 16s RNA gene.
The PCR assay is an accurate and rapid detection method Table 3 . PCR results of Toxoplasma gondii B1 gene and 16s RNA amplification on tissue infected with different protozoan parasites.
for T. gondii in animal tissues, especially when only a small amount of tissue is available. The sensitivity of PCR assays for T. gondii detection is such that only very small tissue quantities are needed to make a definitive diagnosis. Previous work has shown that as little as 0.05 pg of T. gondii DNA, corresponding to 1-2 organisms, is required to obtain a positive amplification reaction. 12 Enough DNA from the T. gondii genome must be available for primer annealing and subsequent amplification. Sampling errors in which zoites or a cyst are not included in the sample material can result in time delays or false negatives. However, repeating the assay using a different tissue section and area is often sufficient to make a definitive diagnosis.
Many different T. gondii strains of varying virulence exist, and it was not clear whether amplification and/or probe hybridization would occur among isolates from different host species. Results of this study indicate that the B1 gene is conserved sufficiently for reliable use as a successful target for amplification.
In spite of its conservation throughout the many strains of T. gondii, the B1 gene is usually specific enough that closely related organisms, known to parasitize similar hosts, may be differentiated from T. gondii by PCR amplification 2 For example, Neospora may appear histologically identical to Toxoplasma and ambiguous via immunohistochemistry, and yet as shown it may be quickly differentiated by PCR assay. The only other diagnostic method commonly employed is elec-
Autoradiograph of a Southern blot identifying the B1 gene of T. gondii recovered in various animal species after amplification and probing with a 32 P-labeled DNA probe: Lanes: 1, avian muscle; 2, feline brain; 3, feline brain; 4, manatee brain; 5, guinea pig spleen; 6, feline spleen; 7, feline muscle; 8, civet lung; 9, kangaroo muscle; 10, kangaroo intestine; 11, wallaby brain; 12, positive control (purified T. gondii DNA); 13, negative control. Molecular sizes are given at the margins in nucleotide base pairs. Identification of a 194-bp product indicates the presence of the B1 gene. tron microscopy, which is costly and time consuming. Similarly, Hammondia also may be serologically cross-reactive with T. gondii 9 and yet distinguishable through application of PCR. 12 The only instance in which B1 primer amplification and subsequent hybridization was not definitive occurred with Sarcocystis-infected cases. Amplification and probing of Sarcocystis-infected tissue with B1 primers and probe yielded positive results, indicating that the B1 gene is highly conserved between Sarcocystis and Toxoplasma species. Although assessment of the B1 gene is not sufficient to differentiate between Sarcocystis and Toxoplasma infection, analysis using P30 primers will differentiate between these organisms.
The use of PCR for differentiation is faster and less ex- Table 4 . Positive results of PCR amplification using Toxoplasma gondii B1 gene primers and 32 P-labeled probe in paraffin-embedded tissues containing protozoa1 cysts. pensive than transmission electron microscopy, tissue cul-7. ture, and in some cases immunohistochemistry. Although differentiation of Sarcocystis-infected samples required double primer identification, this PCR procedure is still less time consuming and more specific than any of the other methods available. PCR should be considered a reliable, rapid, inexpensive, and definitive method of identification for T. gondii infection in formalin-fixed, paraffin-embedded material.
